These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas]. Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682 [TBL] [Abstract][Full Text] [Related]
29. SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. Langen KJ; Coenen HH; Roosen N; Kling P; Muzik O; Herzog H; Kuwert T; Stöcklin G; Feinendegen LE J Nucl Med; 1990 Mar; 31(3):281-6. PubMed ID: 2155314 [TBL] [Abstract][Full Text] [Related]
30. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230 [TBL] [Abstract][Full Text] [Related]
31. Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case. Mineura K; Yasuda T; Kowada M; Sakamoto T; Ogawa T; Shishido F; Uemura K Pediatr Neurosci; 1985-1986; 12(4-5):208-12. PubMed ID: 3039475 [TBL] [Abstract][Full Text] [Related]
32. Neuroimaging of juvenile pilocytic astrocytomas: an enigma. Fulham MJ; Melisi JW; Nishimiya J; Dwyer AJ; Di Chiro G Radiology; 1993 Oct; 189(1):221-5. PubMed ID: 8372197 [TBL] [Abstract][Full Text] [Related]
33. Introduction to imaging brain tumor metabolism with positron emission tomography (PET). Conti PS Cancer Invest; 1995; 13(2):244-59. PubMed ID: 7874578 [TBL] [Abstract][Full Text] [Related]
34. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416 [TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography and brain tumours. Goldman S; Wikler D; Damhaut P; Monclus M; Levivier M; Pirotte B; De Witte O; Brotchi J; Hildebrand J Acta Neurol Belg; 1997 Sep; 97(3):183-6. PubMed ID: 9345590 [TBL] [Abstract][Full Text] [Related]
36. Brain metastases from non-central nervous system tumors: evaluation with PET. Griffeth LK; Rich KM; Dehdashti F; Simpson JR; Fusselman MJ; McGuire AH; Siegel BA Radiology; 1993 Jan; 186(1):37-44. PubMed ID: 8416584 [TBL] [Abstract][Full Text] [Related]
37. [Clinical indications for PET of the central nervous system: primary brain tumors, vascular and degenerative dementia]. Bicik I; von Schulthess GK Schweiz Rundsch Med Prax; 1993 Aug; 82(34):905-9. PubMed ID: 8372294 [TBL] [Abstract][Full Text] [Related]
38. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831 [TBL] [Abstract][Full Text] [Related]
39. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. Lorberboym M; Baram J; Feibel M; Hercbergs A; Lieberman L Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):249-54. PubMed ID: 7721624 [TBL] [Abstract][Full Text] [Related]
40. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme. Korkmaz M; Kim EE; Wong FC; Podoloff DA Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]